Bentoquatam
Ivy Block (bentoquatam) is an unknown pharmaceutical. Bentoquatam was first approved as Ivy block on 1996-08-26.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Ivy block
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bentoquatam
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| IVY BLOCK | Standard Homeopathic | N-020532 OTC | 1996-08-26 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| i.c. ivy block | OTC monograph final | 2021-09-24 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
53 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | 11 | 1 | — | — | — | 11 | |
| Myeloid leukemia acute | D015470 | C92.0 | 5 | 2 | — | — | — | 6 | |
| Non-hodgkin lymphoma | D008228 | C85.9 | 5 | 1 | — | — | — | 6 | |
| Lymphoma | D008223 | C85.9 | 5 | 1 | — | — | — | 5 | |
| Myelodysplastic syndromes | D009190 | D46 | 4 | 1 | — | — | — | 5 | |
| Large b-cell lymphoma diffuse | D016403 | C83.3 | 3 | 2 | — | — | — | 5 | |
| Mantle-cell lymphoma | D020522 | C83.1 | 3 | 1 | — | — | — | 4 | |
| T-cell lymphoma peripheral | D016411 | C84.9 | 2 | 2 | — | — | — | 4 | |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 2 | — | — | — | 4 |
| Large-cell lymphoma anaplastic | D017728 | C84.6 | 2 | 1 | — | — | — | 3 |
Show 19 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 4 | — | — | — | — | 4 | |
| Hematologic neoplasms | D019337 | 3 | — | — | — | — | 3 | ||
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 3 | — | — | — | — | 3 | |
| Hodgkin disease | D006689 | C81 | 3 | — | — | — | — | 3 | |
| Follicular lymphoma | D008224 | C82 | 3 | — | — | — | — | 3 | |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | — | — | — | — | 3 |
| B-cell chronic lymphocytic leukemia | D015451 | C91.1 | 2 | — | — | — | — | 2 | |
| B-cell lymphoma marginal zone | D018442 | C88.4 | 2 | — | — | — | — | 2 | |
| Waldenstrom macroglobulinemia | D008258 | C88.0 | 2 | — | — | — | — | 2 | |
| Intraocular lymphoma | D064090 | 2 | — | — | — | — | 2 |
Show 19 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | BENTOQUATAM |
| INN | — |
| Description | Bentoquatam is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 1302-78-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201446 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
121 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more